UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 56 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $316,000 | +72.7% | 52,683 | +50.5% | 0.00% | – |
| Q4 2020 | $183,000 | +51.2% | 35,000 | 0.0% | 0.00% | – |
| Q3 2020 | $121,000 | -75.6% | 35,000 | -38.7% | 0.00% | – |
| Q2 2020 | $496,000 | +77.8% | 57,142 | +18.7% | 0.00% | – |
| Q1 2020 | $279,000 | -6.4% | 48,142 | +16.4% | 0.00% | – |
| Q4 2019 | $298,000 | +18.3% | 41,342 | 0.0% | 0.00% | – |
| Q3 2019 | $252,000 | -23.2% | 41,342 | +19.7% | 0.00% | – |
| Q2 2019 | $328,000 | +43.9% | 34,542 | +22.7% | 0.00% | – |
| Q1 2019 | $228,000 | +1.3% | 28,142 | +103.3% | 0.00% | – |
| Q4 2018 | $225,000 | – | 13,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |